The invention relates to an magnetic resonance imaging method which localizes an interventional device.
Such an magnetic resonance imaging method is known from the U.S. Pat. No. 6,574,497.
In the known magnetic resonance imaging method compounds containing 19F material are used as a contrast agent in interventional magnetic resonance angiography. The known method makes use of the circumstance that 19F has a reasonable sensitivity compared to protons at the RF-frequency range employed in current MR scanners. The lumen of the interventional device is filled with the 19F contrast agent. The magnetic resonance image that is reconstructed from the magnetic resonance signals acquired at the conventional RF-frequency range displays the interventional device relative to the anatomy of the patient when the interventional device is introduced in the patient's body. Accordingly, the position of the interventional device is found from the magnetic resonance image, that is the interventional device is localised within the patient's body.
An object of the invention is to provide an magnetic resonance imaging method which more accurately localises the interventional device.
This object is achieved by an magnetic resonance imaging method of the invention wherein
localisation magnetic resonance signals are acquired which represent the actual position of at least a pre-selected portion of an interventional device,
the localisation magnetic resonance signals being acquired at a localisation RF-frequency range
imaging magnetic resonance signals are acquired which represent image information
the imaging magnetic resonance signals being acquired at an imaging RF-frequency range.
The present invention employs two different RF-frequency ranges or bands, viz. at the localisation RF-frequency and at the imaging RF-frequency, respectively. At these respective RF-frequency ranges different types of magnetic resonance signals are acquired. At the localisation RF-frequency a high sensitivity for the position of the interventional device is achieved. At the imaging RF-frequency a high sensitivity for image information, i.e. contrast resolution, of the anatomical structures of the patient to be examined is achieved. That is, by employing separate RF-frequency bands for the localisation and imaging respectively, the acquisition of magnetic resonance signals for localisation and for imaging respectively are independently optimised. The localisation magnetic resonance signals at the localisation RF-frequency include information on the position of the interventional device. The imaging magnetic resonance signals include image information of the object into which the interventional device is introduced. The object is notably a patient to be examined. Hence, on the basis of the localisation magnetic resonance signals and the imaging magnetic resonance signals the actual position of at least the pre-selected portion of the interventional device is established relative to the object, notably the patient's anatomy. These and other aspects of the invention will be further elaborated with reference to the embodiments defined in the dependent Claims.
The localisation magnetic resonance signals and the imaging magnetic resonance signals are spatially encoded by way of magnetic gradient fields that define a common frame of reference. Thus, the localisation magnetic resonance signals represent the position of the pre-selected portion of the interventional device in the frame of reference that is in common with the magnetic resonance image reconstructed from the imaging magnetic resonance signals. Accordingly, the position of the pre-selected portion can be accurately shown in the magnetic resonance image. The pre-selected portion notably has a high sensitivity for MR-excitation at the localisation RF-frequency. This is notably achieved in that the pre-selected portion contains a compound including a nucleus that has its precession (Larmor) frequency in the of the localisation RF-frequency range. Hence, the localisation magnetic resonance signals have a high signal level that is easily and accurately detected. Magnetic resonance acquisition sequences to localise the tip of a catheter that operate at the proton frequency band are known per se from the European patent application EP 0 731 362 and from the international application WO01/73460.
The invention may be employed in a local mode where the localisation magnetic resonance signals pertain to a pre-selected portion of the interventional device. A particular example of the pre-selected portion is notably the distal end of a catheter. For example an expandable balloon is often mounted at the distal end of the catheter. According to one aspect of the invention an amount of a localisation compound, such as a 19F-compound, is contained in the balloon. The invention may also be employed in a global mode where the localisation magnetic resonance signals pertain to a large portion, —e.g. essentially the most of—the interventional device. This is for example achieved in that the interventional device includes a lumen, or several lumen compartments that extend along the length of the interventional device. This lumen or lumen compartments may be filled with the localisation compound.
According to a further aspect of the invention a magnetic resonance image is reconstructed from both the localisation magnetic resonance signals as well as from the imaging magnetic resonance signals. This reconstructed magnetic resonance image shows the interventional device, or at least its pre-selected portion, within the anatomical surrounding that is represented by the imaging magnetic resonance signals.
Suitable materials for the localisation compound are 19F-compounds, such as C19F3-compounds. A good example appears to be perfluorooctylbromide (C819FBr)(PFOB) These 19F-compounds have a high sensitivity for selective excitation in the RF-frequency range given by ωo=γ|B0|, where ω0 is the central frequency in the RF-frequency range, γ is the relevant gyromagnetic ratio, e.g. when a 19F compound is used, γ=40.06 MHz/T and B0 is the field strength of the main magnetic field. Good results are achieved when the localisation magnetic resonance signals are acquired at a bandwidth of 1.984 MHz. At this bandwidth—C19F3 resonances are selectively excited and in particular perturbation due to signal from C19F2 groups are avoided.
According to one aspect of the invention the localization magnetic resonance signals are acquired while one or several magnetic read gradient fields in respective—notably orthogonal—directions, are successively activated. These magnetic read gradient provide sufficient spatial encoding of the localization magnetic resonance signals to establish the position of notably the pre-selected portion of the interventional device. Notably, there is no specific need to acquire localization magnetic resonance signals that enable to fully image the pre-selected portion of the interventional device. Hence, the localization magnetic resonance signals may be non-phase-encoded. This acquisition scheme enables a very rapid acquisition of the localization magnetic resonance signals. Further, this acquisition scheme is operated in the localization RF-frequency band.
The invention also relates to an magnetic resonance imaging system as defined in claim 8. The magnetic resonance imaging system of the invention enables to carry out the magnetic resonance imaging method of the invention and hence to accurately localise the interventional device within the patient's body. The invention further relates to a computer programme as defined in claim 9. The computer programme can be loaded into the working memory of the processor of am magnetic resonance imaging system to enable the magnetic resonance imaging system to carry out the magnetic resonance imaging method of the invention which accurately localises the interventional device within the patient's body. The computer programme of the invention can be supplied on a data carrier such as a CD-rom. Alternatively, the computer programme of the invention can be supplied in the form of e.g. digital, datasets that can be downloaded from a data network such as the world-wide web.
Further, the invention pertains to an interventional device as defined in claim 7. The interventional device of the invention comprises a pre-selected portion that functions as a reservoir to contain a 19F-compound, such as a C19F-compound. The interventional device is notably suitable to be localised by way of the magnetic resonance imaging method of the invention.
These and other aspects of the invention will be elucidated with reference to the embodiments described hereinafter and with reference to the accompanying drawing wherein
It is to be noted that it is alternatively possible to use separate receiving and/or transmission coils 16. For example, surface coils 16 can be used as receiving and/or transmission coils. Such surface coils have a high sensitivity in a comparatively small volume. The receiving coils, such as the surface coils, are connected to a demodulator 24 and the received magnetic resonance signals (MS) are demodulated by means of the demodulator 24. The demodulated magnetic resonance signals (DMS) are applied to a reconstruction unit. The receiving coil is connected to a preamplifier 23. The preamplifier 23 amplifies the RF resonance signal (MS) received by the receiving coil 16 and the amplified RF resonance signal is applied to a demodulator 24. The demodulator 24 demodulates the amplified RF resonance signal. The demodulated resonance signal contains the actual information concerning the local spin densities in the part of the object to be imaged. Furthermore, the transmission and receiving circuit 15 is connected to a modulator 22. The modulator 22 and the transmission and receiving circuit 15 activate the transmission coil 13 so as to transmit the RF excitation and refocusing pulses. The reconstruction unit derives one or more image signals from the demodulated magnetic resonance signals (DMS), which image signals represent the image information of the imaged part of the object to be examined. The reconstruction unit 25 in practice is constructed preferably as a digital image processing unit 25 which is programmed so as to derive from the demodulated magnetic resonance signals the image signals which represent the image information of the part of the object to be imaged. The signal on the output of the reconstruction monitor 26, so that the monitor can display the magnetic resonance image. It is alternatively possible to store the signal from the reconstruction unit 25 in a buffer unit 27 while awaiting further processing.
The magnetic resonance imaging system according to the invention is also provided with a control unit 20, for example in the form of a computer which includes a (micro)processor. The control unit 20 controls the execution of the RF excitations and the application of the temporary gradient fields. To this end, the computer program according to the invention is loaded, for example, into the control unit 20 and the reconstruction unit 25.
Notably, the control unit is arranged, e.g. by way of the computer programme of the invention, to enable acquiring magnetic resonance signals in the localisation RF-frequency and in the imaging RF-frequency ranges. To this end the control unit controls the transmission and receiving circuit 15 to operate in these respective frequency ranges. Also the reconstruction unit 25 is arranged to reconstruct the magnetic resonance image from the magnetic resonance signals from both RF-frequency ranges to provide the magnetic resonance image that accurately localises the interventional device 40.
As an alternative to localise the interventional device, interleaved projections using a 19F steady state free precession (SSFP) sequence are employed.
Number | Date | Country | Kind |
---|---|---|---|
04252513.9 | Apr 2004 | EP | regional |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB05/51383 | 4/28/2005 | WO | 10/26/2006 |